Treatment with chloroquine sulphate or chloroquine phosphate or hydroxychloroquine
Cardiomyopathy - Treatment with chloroquine sulphate or chloroquine phosphate or hydroxychloroquine Factor
Last reviewed for CCPS 18 July 2007.
Preliminary questions [38034]
38035 there is some evidence that being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine may be a factor in the development or worsening of the condition under consideration.
38534 the veteran has been treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine at some time.
38036 the veteran has been treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least one year at some time.
38039 — the veteran has established the causal connection between being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine and VEA service for the condition under consideration.
38040 — the veteran has established the causal connection between being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine and VEA service for the clinical onset of the condition under consideration.
38042 — the veteran has established the causal connection between being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine and operational service for the clinical onset of the condition under consideration.
or
38043 — the veteran has established the causal connection between being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine and eligible service for the clinical onset of the condition under consideration.
or
the clinical onset of the condition under consideration occurred after the end of the veteran's last period of VEA service. the condition under consideration permanently worsened.38041 — the veteran has established the causal connection between being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine and VEA service for the clinical worsening of the condition under consideration.
38044 — the veteran has established the causal connection between being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine and operational service for the clinical worsening of the condition under consideration.
or
38045 — the veteran has established the causal connection between being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine and eligible service for the clinical worsening of the condition under consideration.
Clinical onset and operational service [38042]
the veteran was treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least the one year before the clinical onset of the condition under consideration. operational service made a material contribution to the veteran being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least the one year before the clinical onset of the condition under consideration.or
the veteran being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least one year was materially contributed to by treatment of an illness or injury which is identifiable. the identified illness or injury made a material contribution to the veteran being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least the one year before the clinical onset of the condition under consideration.38061 — the identified illness or injury which made a material contribution to the veteran being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least one year is causally related to operational service.
Clinical onset and eligible service [38043]
the veteran has been treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least two years at some time. the veteran was treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least the two years before the clinical onset of the condition under consideration. eligible service made a material contribution to the veteran being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least the two years before the clinical onset of the condition under consideration.or
the veteran being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least one year was materially contributed to by treatment of an illness or injury which is identifiable. the identified illness or injury made a material contribution to the veteran being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least two years. the identified illness or injury made a material contribution to the veteran being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least the two years before the clinical onset of the condition under consideration.38062 — the identified illness or injury which made a material contribution to the veteran being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least two years is causally related to eligible service.
Clinical worsening and operational service [38044]
the veteran was treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine after the clinical onset of cardiomyopathy and for at least the one year before the clinical worsening of the condition under consideration. operational service made a material contribution to the veteran being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine after the clinical onset of cardiomyopathy and for at least the one year before the clinical worsening of the condition under consideration.or
the veteran being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least one year was materially contributed to by treatment of an illness or injury which is identifiable. the identified illness or injury made a material contribution to the veteran being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine after the clinical onset of cardiomyopathy and for at least the one year before the clinical worsening of the condition under consideration.38061 — the identified illness or injury which made a material contribution to the veteran being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least one year is causally related to operational service.
the clinical onset of the condition under consideration occurred prior to that part of operational service to which the identified illness or injury, which made a material contribution to the veteran being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least one year, is causally related.Clinical worsening and eligible service [38045]
the veteran has been treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least two years at some time. the veteran was treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine after the clinical onset of cardiomyopathy and for at least the two years before the clinical worsening of the condition under consideration. eligible service made a material contribution to the veteran being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine after the clinical onset of cardiomyopathy and for at least the two years before the clinical worsening of the condition under consideration.or
the veteran being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least one year was materially contributed to by treatment of an illness or injury which is identifiable. the identified illness or injury made a material contribution to the veteran being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least two years. the identified illness or injury made a material contribution to the veteran being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine after the clinical onset of cardiomyopathy and for at least the two years before the clinical worsening of the condition under consideration.38062 — the identified illness or injury which made a material contribution to the veteran being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least two years is causally related to eligible service.
the clinical onset of the condition under consideration occurred prior to that part of eligible service to which the identified illness or injury, which made a material contribution to the veteran being treated daily with chloroquine sulphate, chloroquine phosphate or hydroxychloroquine for at least two years, is causally related.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/c-d/cardiomyopathy-g021-4254-425964866748/rulebase-cardiomyopathy/treatment-chloroquine-sulphate-or-chloroquine-phosphate-or-hydroxychloroquine